The so far accepted mechanism of the Stille reaction (palladium-catalyzed cross-coupling of organotin reagents with organic electrophiles) is criticized. Based on kinetic studies on catalytic reactions, and on reactions with isolated intermediates, a corrected mechanism is proposed. The couplings between R, and [AsPh 3 ] ) 0-0.07 mol L -1 , at 322.6 K in THF. The only organopalladium(II) intermediate detected under catalytic conditions is 3a. The apparent activation parameters found for the coupling of 1 with 2a support an associative transmetalation step (∆H q obs ) 50 ( 2 kJ mol -1 , ∆S q obs ) -155 ( 7 J K -1 mol -1 in THF; and ∆H q obs ) 70.0 ( 1.7 kJ mol -1 , ∆S q obs ) -104 (). The reactions of 2a with isolated trans-[PdR 1 X(AsPh 3 ) 2 ] (X ) halide) show rates Cl > Br > I. From these observations, the following mechanism is proposed: Oxidative addition of R 1 X to PdL n gives cis-[PdR 1 XL 2 ], which isomerizes rapidly to trans-[PdR 1 XL 2 ]. This trans complex reacts with the organotin compound following a S E 2 (cyclic) mechanism, with release of AsPh 3 (which explains the retarding effect of the addition of L), to give a bridged intermediate [PdR 1 L(µ-X)(µ-R 2 )SnBu 3 ]. In other words, an L-for-R 2 substitution on the palladium leads R 2 and R 1 to mutually cis positions. From there the elimination of XSnBu 3 yields a three-coordinate species cis-[PdR 1 R 2 L], which readily gives the coupling product R 1 -R 2 .
AuR 1 (tht)] (3a) (R 1 ) 3,5-C 6 Cl 2 F 3 , tht ) tetrahydrothiophene) very efficiently catalyzes the isomerization of trans-[Pd(R 1 ) 2 (tht) 2 ] (1a) to cis-[Pd(R 1 ) 2 (tht) 2 ] in CDCl 3 . The 19 F NMR kinetic study leads to the first-order rate law r iso )and 3a, evidencing that the catalyzed isomerization takes place with aryl-group exchange between Pd(II) and Au(I). An associative mechanism passing through R-bridged intermediates [(tht)(R 1 ) 2 Pd(µ-R 2 )Au(tht)] and a donor-acceptor activated complex [(tht)(R 1 ) 2 (R 2 )PdfAu(tht)] q is proposed. The results suggest that the associative displacement of tht from 1a by the nucleophilic arylgold(I) complex to give [(tht)(R 1 ) 2 Pd(µ-R 2 )Au(tht)] is the rate-determining step (k 1 ). This is supported by the typical bimolecular activation parameters that were found: ∆H 1 q ) 56.4 ( 1.6 kJ mol -1 and ∆S 1 q ) -46 ( 6 J K -1 mol -1 .
The relative importance of the factors contributing to the accelerating effect of CuI on [PdL 4 ]-catalyzed couplings of R 1 I and R 2 SnBu 3 (copper effect) has been quantitatively evaluated in THF for R 1 ) 3,5-C 6 Cl 2 F 3 ; R 2 ) vinyl, C 6 H 4 -4-OMe; L ) AsPh 3 , PPh 3 , using spectroscopic and kinetic methods. The 19 F NMR kinetic data show that the rate enhancement produced by addition of CuI is strongly related with the "autoretardation" effect intrinsic to [PdL 4 ] catalysts and is almost independent of the organotin reagent (vinyl, aryl). The "autoretardation" is due to the release of 2 equiv of L during the oxidation of [PdL 4 ] to yield trans-[PdR 1 IL 2 ], which is the species undergoing transmetalation. CuI does not promote the dissociation of L from trans-[PdR 1 IL 2 ], but it captures part of the free neutral ligand L and therefore mitigates the autoretardation produced by the presence of free L on the ratedetermining associative transmetalation. In the conditions studied (Pd:Cu ) 1:2; T ) 322.6 K; THF as solvent), for L ) AsPh 3 the CuI added captures about 25% of the free AsPh 3 and the copper effect compensates only ca. 1% of the autoretardation, whereas for L ) PPh 3 the CuI captures about 99% of the free PPh 3 and the compensation is about 30%. This remarkable variation is caused by the combined effect of two independent factors: (i) The catalyst [Pd-(PPh 3 ) 4 ] is more autoretarded than [Pd(AsPh 3 ) 4 ]; and (ii) CuI is a more effective scavenger for PPh 3 than for AsPh 3 .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.